Select Publications

Journal articles

Saleh D; Lewis A; Liauw W; Lee SH; Ristuccia R; Morris D; Ho S-J, 2018, 'A randomised controlled trial to compare administration of prothrombin complex concentrate with standard haemostasis management in adult patients undergoing peritoneal cytoreductive surgery requiring massive transfusion', Pathology, 50, pp. S59 - S60, http://dx.doi.org/10.1016/j.pathol.2017.12.140

Schwarz L; Levine EA; Morris D; Spiliotis J; Pocard M; Kianmanesh R; Bartlett DL; Glehen O; Tentes A-AK; Villeneuve L, 2018, 'CRS with HIPEC for peritoneal carcinomatosis of pancreatic adenocarcinoma. What do we expect? Results of a Multicenter International Study', HPB, 20, pp. S324 - S324, http://dx.doi.org/10.1016/j.hpb.2018.06.356

Kusamura S; Barattii D; Sugarbaker PH; Elias D; Glehen O; Levine E; Morris DL; De Simone M; Yonemura Y; Deraco M, 2018, 'Drug combinations for hipec after cytoreductive surgery in diffuse malignant peritoneal mesothelioma: A PSOGI registry study', European Journal of Surgical Oncology, 44, pp. e5 - e5, http://dx.doi.org/10.1016/j.ejso.2018.07.021

Ataie-Kachoie P; Pillai K; Badar S; Akhter J; Morris DL, 2018, 'Monepantel considerably enhances the therapeutic potentials of PEGylated liposomal doxorubicin and gemcitabine in ovarian cancer: in vitro and in vivo studies.', Am J Cancer Res, 8, pp. 2064 - 2075, https://www.ncbi.nlm.nih.gov/pubmed/30416856

Morris DL, 2018, 'Peer review report 2 on “Dose surgical resection of hepatic metastases bring benefits to pancreatic ductal adenocarcinoma? A systematic review and meta-analysis”', International Journal of Surgery, 49, pp. 16 - 16, http://dx.doi.org/10.1016/j.ijsu.2017.11.021

Kozman MA; Fisher OM; Rebolledo BAJ; Valle SJ; Alzahrani N; Liauw W; Morris DL, 2017, 'CA 19-9 to peritoneal carcinomatosis index (PCI) ratio is prognostic in patients with epithelial appendiceal mucinous neoplasms and peritoneal dissemination undergoing cytoreduction surgery and intraperitoneal chemotherapy: A retrospective cohort study', European Journal of Surgical Oncology, 43, pp. 2299 - 2307, http://dx.doi.org/10.1016/j.ejso.2017.09.009

Huang Y; Alzahrani NA; Liauw W; Soudy H; Alzahrani AM; Morris DL, 2017, 'Early postoperative intraperitoneal chemotherapy is associated with survival benefit for appendiceal adenocarcinoma with peritoneal dissemination', European Journal of Surgical Oncology, 43, pp. 2292 - 2298, http://dx.doi.org/10.1016/j.ejso.2017.09.002

Morris DL, 2017, 'Reply: “Adjuvant” Hyperthermic Intraperitoneal Chemotherapy: A Call to Action', Annals of Surgical Oncology, 24, pp. 616, http://dx.doi.org/10.1245/s10434-017-6171-1

Alzahrani N; Ung L; Valle SJ; Liauw W; Morris DL, 2017, 'Synchronous liver resection with cytoreductive surgery for the treatment of liver and peritoneal metastases from colon cancer: results from an Australian centre', ANZ Journal of Surgery, 87, pp. E167 - E172, http://dx.doi.org/10.1111/ans.13231

Kim B; Alzahrani N; Valle SJ; Liauw W; Morris DL, 2017, 'Treatment-related post-operative mortality after cytoreductive surgery and perioperative intraperitoneal chemotherapy', Journal of Peritoneum (and other serosal surfaces), http://dx.doi.org/10.4081/joper.2017.65

Bin Traiki TA; Fisher OM; Valle SJ; Parikh RN; Kozman MA; Glenn D; Power M; Liauw W; Alzahrani NA; Morris DL, 2017, 'Percutaneous lung ablation of pulmonary recurrence may improve survival in selected patients undergoing cytoreductive surgery for colorectal cancer with peritoneal carcinomatosis', European Journal of Surgical Oncology, 43, pp. 1939 - 1948, http://dx.doi.org/10.1016/j.ejso.2017.08.005

Saxena A; Valle SJ; Liauw W; Morris DL, 2017, 'Recurrence and survival outcomes after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for small bowel adenocarcinoma', Anticancer Research, 37, pp. 5737 - 5742, http://dx.doi.org/10.21873/anticanres.12012

Pardo F; Sangro B; Lee RC; Manas D; Jeyarajah R; Donckier V; Maleux G; Pinna AD; Bester L; Morris DL; Iannitti D; Chow PK; Stubbs R; Gow PJ; Masi G; Fisher KT; Lau WY; Kouladouros K; Katsanos G; Ercolani G; Rotellar F; Bilbao JI; Schoen M, 2017, 'The Post-SIR-Spheres Surgery Study (P4S): Retrospective Analysis of Safety Following Hepatic Resection or Transplantation in Patients Previously Treated with Selective Internal Radiation Therapy with Yttrium-90 Resin Microspheres', Annals of Surgical Oncology, 24, pp. 2465 - 2473, http://dx.doi.org/10.1245/s10434-017-5950-z

Saxena A; Valle SJ; Liauw W; Morris DL, 2017, 'Allogenic Blood Transfusion Is an Independent Predictor of Poorer Peri-operative Outcomes and Reduced Long-Term Survival after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: a Review of 936 Cases', Journal of Gastrointestinal Surgery, 21, pp. 1318 - 1327, http://dx.doi.org/10.1007/s11605-017-3444-8

Saxena A; Liauw W; Morris DL, 2017, 'Splenectomy is an independent risk factor for poorer perioperative outcomes after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: An analysis of 936 procedures', Journal of Gastrointestinal Oncology, 8, pp. 737 - 746, http://dx.doi.org/10.21037/jgo.2017.07.09

Pillai K; Akhter J; Morris DL, 2017, 'Assessment of a novel mucolytic solution for dissolving mucus in pseudomyxoma peritonei: An ex vivo and in vitro study', Pleura and Peritoneum, 2, pp. 111 - 117, http://dx.doi.org/10.1515/pp-2017-0013

Huang Y; Alzahrani NA; Chua TC; Liauw W; Morris DL, 2017, 'Repeat cytoreductive surgery with or without perioperative intraperitoneal chemotherapy for peritoneal surface malignancy', American Journal of Surgery, 213, pp. 1024 - 1030, http://dx.doi.org/10.1016/j.amjsurg.2016.09.046

Huo YR; Phan K; Morris DL; Liauw W, 2017, 'Systematic review and a meta-analysis of hospital and surgeon volume/outcome relationships in colorectal cancer surgery', Journal of Gastrointestinal Oncology, 8, pp. 534 - 546, http://dx.doi.org/10.21037/jgo.2017.01.25

Kozman MA; Fisher OM; Valle SJ; Alzahrani N; Morris DL, 2017, 'The use of carbon dioxide insufflation to facilitate identification of intestinal injuries in patients undergoing cytoreductive surgery and intraperitoneal chemotherapy', Techniques in Coloproctology, 21, pp. 479 - 480, http://dx.doi.org/10.1007/s10151-017-1644-6

Mamoori A; Gopalan V; Lu CT; Chua TC; Morris DL; Smith RA; Lam AKY, 2017, 'Expression pattern of miR-451 and its target MIF (macrophage migration inhibitory factor) in colorectal cancer', Journal of clinical pathology, 70, pp. 308 - 312, http://dx.doi.org/10.1136/jclinpath-2016-203972

Huang Y; Alzahrani NA; Chua TC; Morris DL, 2017, 'Histological Subtype Remains a Significant Prognostic Factor for Survival Outcomes in Patients with Appendiceal Mucinous Neoplasm with Peritoneal Dissemination', Diseases of the Colon and Rectum, 60, pp. 360 - 367, http://dx.doi.org/10.1097/DCR.0000000000000719

Saxena A; Valle SJ; Liauw W; Morris DL, 2017, 'Limited synchronous hepatic resection does not compromise peri-operative outcomes or survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy', Journal of Surgical Oncology, 115, pp. 417 - 424, http://dx.doi.org/10.1002/jso.24543

Kyang LS; Alzahrani NA; Zhao J; Morris DL, 2017, 'Gastric perforation following cytoreductive surgery and perioperative intraperitoneal chemotherapy: A case series of six', World Journal of Surgical Oncology, 15, http://dx.doi.org/10.1186/s12957-017-1114-7

Masoumi-Moghaddam S; Amini A; Morris DL, 2017, 'Is mucin a determinant of peritoneal dissemination of gastrointestinal cancer? Analysis of mucin depletion in two preclinical models', Clinical and Translational Oncology, 19, pp. 261 - 264, http://dx.doi.org/10.1007/s12094-016-1519-8

Huang Y; Alzahrani NA; Liauw W; Traiki TB; Morris DL, 2017, 'Early Postoperative Intraperitoneal Chemotherapy for Low-Grade Appendiceal Mucinous Neoplasms with Pseudomyxoma Peritonei: Is it Beneficial?', Annals of Surgical Oncology, 24, pp. 176 - 183, http://dx.doi.org/10.1245/s10434-016-5529-0

Huo YR; Glenn D; Liauw W; Power M; Zhao J; Morris DL, 2017, 'Evaluation of carcinoembryonic antigen (CEA) density as a prognostic factor for percutaneous ablation of pulmonary colorectal metastases', European Radiology, 27, pp. 128 - 137, http://dx.doi.org/10.1007/s00330-016-4352-0

Huang Y; Alzahrani NA; Liauw W; Morris DL, 2017, 'Learning curve for cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis', ANZ Journal of Surgery, 87, pp. 49 - 54, http://dx.doi.org/10.1111/ans.13280

Suh H; Pillai K; Morris DL, 2017, 'Mucins in pancreatic cancer: Biological role, implications in carcinogenesis and applications in diagnosis and therapy', American Journal of Cancer Research, 7, pp. 1372 - 1383

Leung V; Huo YR; Liauw W; Morris DL, 2017, 'Oxaliplatin versus Mitomycin C for HIPEC in colorectal cancer peritoneal carcinomatosis', European Journal of Surgical Oncology, 43, pp. 144 - 149, http://dx.doi.org/10.1016/j.ejso.2016.09.015

Pillai K; Akhter J; Mekkawy A; Chua TC; Morris DL, 2017, 'Physical and chemical characteristics of mucin secreted by pseudomyxoma peritonei (PMP)', International Journal of Medical Sciences, 14, pp. 18 - 28, http://dx.doi.org/10.7150/ijms.16422

Pillai K; Akhter J; Morris DL, 2017, 'Super Aqueous Solubility of Albendazole in β-Cyclodextrin for Parenteral Application in Cancer therapy', Journal of Cancer, 8, pp. 913 - 923, http://dx.doi.org/10.7150/jca.17301

Suh H; Valle S; Morris DL, 2017, 'Targeting MUC16 in Cancer Therapy', Chemotherapy: Open Access, 06, http://dx.doi.org/10.4172/2167-7700.1000235

Alzahrani N; Ferguson JS; Valle SJ; Liauw W; Chua T; Morris DL, 2016, 'Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: long-term results at St George Hospital, Australia', ANZ Journal of Surgery, 86, pp. 937 - 941, http://dx.doi.org/10.1111/ans.13152

Valle SJ; Alzahrani N; Alzahrani S; Traiki TB; Liauw W; Morris DL, 2016, 'Enterocutaneous fistula in patients with peritoneal malignancy following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: Incidence, management and outcomes', Surgical Oncology, 25, pp. 315 - 320, http://dx.doi.org/10.1016/j.suronc.2016.05.025

Yonemura Y; Canbay E; Li Y; Coccolini F; Glehen O; Sugarbaker PH; Morris D; Moran B; Gonzaletz-Moreno S; Deraco M; Piso P; Elias D; Batlett D; Ishibashi H; Mizumoto A; Verwaal V; Mahtem H, 2016, 'A comprehensive treatment for peritoneal metastases from gastric cancer with curative intent', European Journal of Surgical Oncology, 42, pp. 1123 - 1131, http://dx.doi.org/10.1016/j.ejso.2016.03.016

Huang Y; Alzahrani NA; Chua TC; Liauw W; Morris DL, 2016, 'Impacts of peritoneal cancer index on the survival outcomes of patients with colorectal peritoneal carcinomatosis', International Journal of Surgery, 32, pp. 65 - 70, http://dx.doi.org/10.1016/j.ijsu.2016.06.033

Huang Y; Alzahrani NA; Chua TC; Huo YR; Liauw W; Morris DL, 2016, 'Impacts of Preoperative Serum Albumin Level on Outcomes of Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy', Annals of Surgical Oncology, 23, pp. 2411 - 2418, http://dx.doi.org/10.1245/s10434-016-5172-9

Doyle M; Villanueva C; Davies S; Fermanis G; Horton M; Morris D, 2016, 'Cytoreductive surgery and heated intrathoracic chemotherapy for thoracic extension of Pseudomyxoma peritonei', Integrative Cancer Science and Therapeutics, 3, pp. 504 - 508, http://dx.doi.org/10.15761/ICST.1000198

Lansom J; Alzahrani N; Liauw W; Morris DL, 2016, 'Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei and Appendix Tumours', Indian Journal of Surgical Oncology, 7, pp. 166 - 176, http://dx.doi.org/10.1007/s13193-015-0478-9

Leung V; Huang N; Liauw W; Morris DL, 2016, 'High risk features of primary colorectal carcinomas which subsequently undergo peritonectomy', European Journal of Surgical Oncology, 42, pp. 836 - 840, http://dx.doi.org/10.1016/j.ejso.2015.08.161

Valle SJ; Alzahrani NA; Liauw W; Sugarbaker PH; Bhatt A; Morris DL, 2016, 'Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Methodology, Drugs and Bidirectional Chemotherapy', Indian Journal of Surgical Oncology, 7, pp. 152 - 159, http://dx.doi.org/10.1007/s13193-016-0498-0

Jiang Y; Lu H; Chen F; Callari M; Pourgholami M; Morris DL; Stenzel MH, 2016, 'PEGylated Albumin-Based Polyion Complex Micelles for Protein Delivery', Biomacromolecules, 17, pp. 808 - 817, http://dx.doi.org/10.1021/acs.biomac.5b01537

Huang Y; Alzahrani NA; Chua TC; Huo YR; Morris DL, 2016, 'Clinical outcomes of patients with extensive peritoneal carcinomatosis following cytoreductive surgery and perioperative intraperitoneal chemotherapy', Anticancer Research, 36, pp. 1033 - 1040

Huo YR; Huang Y; Liauw W; Zhao J; Morris DL, 2016, 'Prognostic value of carcinoembryonic antigen (cea), afp, ca19-9 and ca125 for patients with colorectal cancer with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy', Anticancer Research, 36, pp. 1041 - 1050

Huo YR; Pillai K; Akhter J; Morris DL, 2016, '“Edgeboost”: A Novel Technique to Extend the Ablation Zone Lateral to a Two-Probe Bipolar Radiofrequency Device', CardioVascular and Interventional Radiology, 39, pp. 97 - 105, http://dx.doi.org/10.1007/s00270-015-1168-2

Schwarz L; Votanopoulos K; Morris D; Yonemura Y; Deraco M; Piso P; Moran B; Levine EA; Tuech JJ, 2016, 'Is the combination of distal pancreatectomy and cytoreductive surgery with HIPEC reasonable? results of an international multicenter study', Annals of Surgery, 263, pp. 369 - 375, http://dx.doi.org/10.1097/SLA.0000000000001225

Kyang LS; Bin Traiki TA; Alzahrani NA; Morris DL, 2016, 'Microwave ablation of liver metastasis complicated by Clostridium perfringens gas-forming pyogenic liver abscess (GPLA) in a patient with past gastrectomy', International Journal of Surgery Case Reports, 27, pp. 32 - 35, http://dx.doi.org/10.1016/j.ijscr.2016.08.009

Amini A; Masoumi-Moghaddam S; Ehteda A; Liauw W; Morris DL, 2016, 'Potentiation of chemotherapeutics by bromelain and N-acetylcysteine: Sequential and combination therapy of gastrointestinal cancer cells', American Journal of Cancer Research, 6, pp. 350 - 369

Huo Y; Glenn D; Power M; Zhao J; Liauw W; Morris D, 2016, 'CEA failure as a prognostic factor for percutaneous ablation of pulmonary colorectal metastases', Journal of Vascular and Interventional Radiology, 27, pp. S82 - S82, http://dx.doi.org/10.1016/j.jvir.2015.12.218

Huo Y; Glenn D; Power M; Zhao J; Liauw W; Morris D, 2016, 'Evaluation of CEA density as a prognostic factor for percutaneous ablation of pulmonary colorectal metastases', Journal of Vascular and Interventional Radiology, 27, pp. S123 - S123, http://dx.doi.org/10.1016/j.jvir.2015.12.323


Back to profile page